These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33771355)

  • 21. Radiation therapy for patients with locally advanced pancreatic cancer: Evolving techniques and treatment strategies.
    Abi Jaoude J; Kouzy R; Nguyen ND; Lin D; Noticewala SS; Ludmir EB; Taniguchi CM
    Curr Probl Cancer; 2020 Dec; 44(6):100607. PubMed ID: 32471736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Cancer: A Systematic Review and Pooled Analysis of 19 Trials.
    Petrelli F; Comito T; Ghidini A; Torri V; Scorsetti M; Barni S
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):313-322. PubMed ID: 28068239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiotherapy in pancreatic cancer.
    Klautke G; Brunner TB
    Strahlenther Onkol; 2008 Nov; 184(11):557-64. PubMed ID: 19016013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival.
    Massucco P; Capussotti L; Magnino A; Sperti E; Gatti M; Muratore A; Sgotto E; Gabriele P; Aglietta M
    Ann Surg Oncol; 2006 Sep; 13(9):1201-8. PubMed ID: 16955382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The value of chemoradiotherapy in the management of locally advanced pancreatic adenocarcinoma: systematic review].
    Azria D; Seblain-El-Guerche C; Girard N; Hennequin C; Huguet F
    Bull Cancer; 2008 Nov; 95(11):1116-30. PubMed ID: 19036684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolving treatment options for locally advanced unresectable pancreatic ductal adenocarcinoma.
    Cinar P; Ko AH
    J Natl Compr Canc Netw; 2014 Feb; 12(2):167-72. PubMed ID: 24586078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative radiotherapy improves overall survival of pT4 pancreatic ductal adenocarcinoma patients after surgical resection.
    Xu Y; Zhang Y; Wu Z; Wang D; Wu W; Kuang T; Lou W
    Jpn J Clin Oncol; 2020 Jun; 50(6):679-687. PubMed ID: 32372083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Updates and new directions in the use of radiation therapy for the treatment of pancreatic adenocarcinoma: dose, sensitization, and novel technology.
    Hall WA; Kamgar M; Erickson BA; Ponce SB; Tsai S; Nevalainen MT; Christians KK; George B; Dua KS; Khan AH; Evans DB; Azmi AS
    Cancer Metastasis Rev; 2021 Sep; 40(3):879-889. PubMed ID: 34611794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereotactic body radiotherapy using CyberKnife for locally advanced unresectable and metastatic pancreatic cancer.
    Su TS; Liang P; Lu HZ; Liang JN; Liu JM; Zhou Y; Gao YC; Tang MY
    World J Gastroenterol; 2015 Jul; 21(26):8156-62. PubMed ID: 26185389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A treatment planning comparison of four target volume contouring guidelines for locally advanced pancreatic cancer radiotherapy.
    Fokas E; Eccles C; Patel N; Chu KY; Warren S; McKenna WG; Brunner TB
    Radiother Oncol; 2013 May; 107(2):200-6. PubMed ID: 23647755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dosimetric analysis of stereotactic rotational versus static intensity-modulated radiation therapy for pancreatic cancer.
    Cho I; Park JW; Cho B; Kwak J; Yoon SM; Nesseler JP; Park J; Kim JH
    Cancer Radiother; 2018 Dec; 22(8):754-762. PubMed ID: 30322818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II Study of the Triple Combination Chemotherapy of SOXIRI (S-1/Oxaliplatin/Irinotecan) in Patients with Unresectable Pancreatic Ductal Adenocarcinoma.
    Akahori T; Sho M; Yanagimoto H; Satoi S; Nagai M; Nishiwada S; Nakagawa K; Nakamura K; Yamamoto T; Hirooka S; Yamaki S; Ikeda N
    Oncologist; 2019 Jun; 24(6):749-e224. PubMed ID: 30679316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Effects of Radiotherapy on Pancreatic Ductal Adenocarcinoma in Patients with Liver Metastases.
    Wu L; Lu Y; Chen L; Yue X; Cen C; Zheng C; Han P
    Curr Oncol; 2022 Oct; 29(10):7912-7924. PubMed ID: 36290902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraoperative Radiation Therapy (IORT) for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (BR/LA PDAC) in the Era of Modern Neoadjuvant Treatment: Short-Term and Long-Term Outcomes.
    Harrison JM; Wo JY; Ferrone CR; Horick NK; Keane FK; Qadan M; Lillemoe KD; Hong TS; Clark JW; Blaszkowsky LS; Allen JN; Castillo CF
    Ann Surg Oncol; 2020 May; 27(5):1400-1406. PubMed ID: 31758284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-181b-5p, ETS1, and the c-Met pathway exacerbate the prognosis of pancreatic ductal adenocarcinoma after radiation therapy.
    Tomihara H; Yamada D; Eguchi H; Iwagami Y; Noda T; Asaoka T; Wada H; Kawamoto K; Gotoh K; Takeda Y; Tanemura M; Mori M; Doki Y
    Cancer Sci; 2017 Mar; 108(3):398-407. PubMed ID: 28064436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A nationwide randomized controlled trial on additional treatment for isolated local pancreatic cancer recurrence using stereotactic body radiation therapy (ARCADE).
    van Goor IWJM; Daamen LA; Besselink MG; Bruynzeel AME; Busch OR; Cirkel GA; Groot Koerkamp B; Haj Mohammed N; Heerkens HD; van Laarhoven HWM; Meijer GJ; Nuyttens J; van Santvoort HC; van Tienhoven G; Verkooijen HM; Wilmink JW; Molenaar IQ; Intven MPW;
    Trials; 2022 Oct; 23(1):913. PubMed ID: 36307892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereotactic body radiotherapy for pancreatic cancer: recent progress and future directions.
    Myrehaug S; Sahgal A; Russo SM; Lo SS; Rosati LM; Mayr NA; Lock M; Small W; Dorth JA; Ellis RJ; Teh BS; Herman JM
    Expert Rev Anticancer Ther; 2016 May; 16(5):523-30. PubMed ID: 26999329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of the Human Pancreatic Ductal Adenocarcinoma Immune Microenvironment by Stereotactic Body Radiotherapy.
    Mills BN; Qiu H; Drage MG; Chen C; Mathew JS; Garrett-Larsen J; Ye J; Uccello TP; Murphy JD; Belt BA; Lord EM; Katz AW; Linehan DC; Gerber SA
    Clin Cancer Res; 2022 Jan; 28(1):150-162. PubMed ID: 34862242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of radiotherapy in multimodal treatment of pancreatic carcinoma.
    Brunner TB; Scott-Brown M
    Radiat Oncol; 2010 Jul; 5():64. PubMed ID: 20615227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Locally advanced pancreatic cancer: An emerging entity.
    O Kane GM; Knox JJ
    Curr Probl Cancer; 2018; 42(1):12-25. PubMed ID: 29153290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.